BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2005
View Archived Issues
Neuroprotective effects of IBU-PO, a novel bifunctional NSAID-cholinesterase inhibitor
Read More
Glycine transport inhibitors modulate dopamine in vitro
Read More
In vitro and in vivo pharmacology of the novel iNOS inhibitor FR-260330
Read More
Cytotoxic effects of telomerase inhibition with BIBR-1532 in leukemia cells
Read More
MedImmune amends ex-U.S. RSV agreement with Abbott
Read More
Tercica submits NDA for Increlex
Read More
Elusys files IND to begin human safety studies of Anthim
Read More
New phase II study to test TB4 for epidermolysis bullosa
Read More
BioPro takes Asia-Pacific rights to Vantas
Read More
Debiopharm purchases outstanding shares of H3 Pharma
Read More
Ono updates progress of ONO-2506 and inlicensed Merck compounds
Read More
Hexvix approved in 26 European countries
Read More
Enrollment open in phase II study of PTK/ZK in NSCLC
Read More
New phase II study for NeuroVax
Read More
Bionomics completes acquisition of Neurofit
Read More
Geron and BRC create new company for telomerase activation therapies
Read More
Valeant completes Xcel acquisition
Read More
Pivotal trial begins for FK-228 for CTCL
Read More
Procyon Biopharma grants Medicorp rights to PSP94-based test kits
Read More
Phase II data support the use of SPP-301 in diabetic nephropathy
Read More
NRP-104 reported effective in the treatment of ADHD
Read More
ALVAC vCP1452 shows efficacy in preventing viral rebound in HIV-infected patients
Read More
MVA-nef induces a strong specific immune response in HIV-infected patients
Read More
S-236 cream effective in pruritis, xerosis and atopic dermatitis in humans
Read More
Topical compound containing MMP and PKC inhibitors improves skin hypersensitivity in humans
Read More
New title added to the Drug R&D Backgrounders topic list - Autism Spectrum Disorders
Read More
Controlled release formulations for antiinfective therapy claimed
Read More
Two series of serotonin reuptake inhibitors reported by Merck
Read More
Novel anti-hepatitis C virus (HCV) agents discovered at Enanta
Read More
Celltech discloses the development of novel p38 MAP kinases for rheumatoid arthritis
Read More
New immunoglobulin E (IgE) production inhibitors and their use disclosed by Celltech
Read More